Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF (PDBC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.96 (market cap $8.48B), while Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF trades at $19.76 (market cap $7.96B). The key difference: Hinge Health Inc. Class A Common Stock and Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF are close in size by market cap, and Hinge Health Inc. Class A Common Stock is more actively traded (879,799 versus 2,738,146). Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF for 56 Days on average.
| HNGE | PDBC | |
|---|---|---|
Market Cap | $8.48B | $7.96B |
Volume | 879,799 | 2,738,146 |
Sector | Health | — |
52-Week High | $105.14 | $20.10 |
52-Week Low | $31.17 | $13.19 |
Typical Hold Time | 0 Days | 56 Days |
Enterprise Value | $8.10B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
PDBC, an ETF tracking diversified commodities, trades at $19.98, up 0.6% today, with a bullish technical signal from moving averages. The fund has delivered strong performance, rising 45.66% year-to-date through Q3 2026, driven by energy and agricultural gains amid geopolitical tensions. Short interest surged 215.4% in September 2026, indicating increased bearish speculation, while institutional investments from firms like Arlington Capital and Advisortrust Partners show confidence.
The outlook remains positive due to robust commodity trends, but risks include heightened short interest and geopolitical volatility. Investors benefit from broad commodity exposure without K-1 tax complexity, though price swings from supply shocks or economic shifts pose challenges. The fund's momentum and defensive appeal in uncertain markets support a favorable view, but monitoring short-term pressure is essential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF
The fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing in a combination of financial instruments that are economically linked to the world's most heavily traded commodities. Commodities are assets that have tangible properties, such as oil, agricultural produce or raw metals.
Read more on PDBC →
